NEPT
$1.82
Neptune Wellness Solutions
($.03)
(1.62%)
NEPT
Earnings Whisper ®
N/A
4th Quarter March 2020
Consensus:  ($0.04)
Revenue:  $8.77 Mil
Thursday
May 14
6:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Thursday, February 13, 2020

What do you expect when NEPT reports earnings?
Beat
Meet
Miss

Where is NEPT's stock price going from here?
Up
Flat
Down
Stock chart of NEPT
Analysts
Summary of analysts' recommendations for NEPT
Score
Grade
Pivots
Resistance
$1.96
$1.91
$1.86

$1.81

Support
$1.76
$1.71
$1.66
Tweet
Growth
Description
Neptune Technologies & Bioressources Inc. develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process. Using its proprietary process, Neptune Technologies & Bioressources Inc. is strategically positioning itself in the nutraceutical and pharmaceutical health and wellness market. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets, the next wave in nutritional research.
Peers
BiogenAmgenGilead SciencesNeurocrine BiosciencesBluebird BioSeattle GeneticsQiagen N.V.RepligenBioCryst PharmaceuticalsNovavax